Physician profile
Vidit Talati
NPI 1457806648
$2,680.94
in general payments reported to CMS, 2019-2025
8 companies · $300 in 2025
The $300 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $66.07 · 2022: $135 · 2023: $1,463 · 2024: $717 · 2025: $300.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,323 · Travel and Lodging: $1,157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,323.25 |
| Travel and Lodging | $1,156.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,647.12 | 2023-2024 | Clarifix Cryotherapy Device, Latera, Scopis Ent |
| Integra Lifesciences Corporation | $306.63 | 2024 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Aerin Medical INC. | $281.92 | 2022-2024 | |
| Glaxosmithkline, LLC. | $145.37 | 2021-2024 | |
| Neurent Medical Limited | $126.90 | 2025 | Neuromark Radiofrequency Console, Neuromark System |
| Inspire Medical Systems, INC. | $121.99 | 2025 | Inspire |
| Optinose US, INC. | $27.69 | 2025 | |
| Medtronic, INC. | $23.32 | 2025 | Propel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vidit Talati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.